Sulphobutylether-β-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis

International Journal of Antimicrobial Agents

Volumn 36, Issue 1, 2010, Pages 93-94

  Burkhardt, Olaf ^a,b   Thon, Simone ^b   Burhenne, Jürgen ^a   Welte, Tobias ^c   Kielstein, Jan T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Central Clinic Bad Berka   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN SULFOBUTYL ETHER; POLYSULFONE; VORICONAZOLE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; AREA UNDER THE CURVE; CASE REPORT; CRITICALLY ILL PATIENT; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; EXTENDED DAILY DIALYSIS; FEMALE; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY INJURY; LETTER; MALE; MAXIMUM PLASMA CONCENTRATION; MYCOSIS; PRIORITY JOURNAL;

AGED; ANIMALS; ANTIFUNGAL AGENTS; BETA-CYCLODEXTRINS; CRITICAL ILLNESS; FEMALE; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; MYCOSES; PYRIMIDINES; RENAL DIALYSIS; TRIAZOLES;

EID: 77953022966     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.02.017     Document Type: Letter

References (6)

1. Scott L.J., Simpson D. Voriconazole: a review of its use in the management of invasive fungal infections. Drugs 2007, 67:269-298.
2. Burkhardt O., Köhnlein T., Pletz M., Welte T. Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole. Scand J Infect Dis 2005, 37:69-72.
3. Theuretzbacher U., Ihle F., Derendorf H. Pharmacokinetic/pharmacodynamic profile of voriconazole. Clin Pharmacokinet 2006, 45:649-663.
4. Gage R., Venn R.F., Bayliss M.A.J., Edgington A.M., Roffey S.J., Sorrell B. Fluorescence determination of sulphobutylether-β-cyclodextrin in human plasma by size exclusion chromatography with inclusion complex formation. J Pharm Biomed Anal 2000, 22:773-780.
5. Pennick G.J., Clark M., Sutton D.A., Rinaldi M.G. Development and validation of a high-performance liquid chromatography assay for voriconazole. Antimicrob Agents Chemother 2003, 47:2348-2350.
6. von Mach M.A., Burhenne J., Weilemann L.S. Accumulation of the solvent vehicle sulfobutylether β cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy. BMC Clin Pharmacol 2006, 6:6.